Lawrence Alan Leiter

Lawrence Alan Leiter MDCM, FRCPC, FACP, FACE, FAHA
Professor — Status Only
Department of Nutritional Sciences
Lawrence A. Leiter
Contact Info
T: (416) 867-7441
St. Michael's Hospital
61 Queen Street East, 6th Floor
Toronto, ON, M5C 2T2
Appointment Status Cross-Appointed
Not accepting new students


Research Synopsis

Major clinical research areas include:

  • Clinical trials on the prevention of atherosclerosis, especially in diabetes
  • Dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity.
  • Investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and is on the Executive/Steering Committees of many ongoing outcome trials in both the diabetes and lipid areas.

Publications and Awards

View PubMed search of this faculty member's recent publications.

Recent Publications

Leiter LA, Teoh H, Braunwald E, Mosenzon O, Cahn A, Kumar KM, Smahelova A, Hirshberg B, Stahre C, Frederich R, Bonnici F, Scirica BM, Bhatt DL, Raz I; Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial. SAVOR-TIMI 53 Steering Committee and Investigators. Diabetes Care. 2015 Jun;38(6):1145-53.

Leiter LA, Astrup A, Andrews RC, Cuevas A, Horn DB, Kunešová M, Wittert G, Finer N.Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practice. Clin Obes. 2015 Oct;5(5):245-55.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. SAVOR-TIMI 53 Steering Committee and Investigators. N Engl J Med. 2013 Oct 3;369(14):1317-26.

Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoé JM, Fournier C, Goldin L, Harris SB, Lin P, Ransom T, Tan M, Teoh H, Tsuyuki RT, Whitham D, Woo V, Yale JF, Langer A. Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes. 2013 Apr;37(2):82-9.

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).Can J Cardiol. 2011 Mar-Apr;27(2):124-31.